loading
전일 마감가:
$3.35
열려 있는:
$3.34
하루 거래량:
244.46K
Relative Volume:
0.14
시가총액:
$160.82M
수익:
-
순이익/손실:
$-44.80M
주가수익비율:
-4.5333
EPS:
-0.75
순현금흐름:
$-30.67M
1주 성능:
+7.26%
1개월 성능:
+53.15%
6개월 성능:
-28.50%
1년 성능:
+2.10%
1일 변동 폭
Value
$3.29
$3.45
1주일 범위
Value
$2.95
$3.45
52주 변동 폭
Value
$1.14
$7.20

Aldeyra Therapeutics Inc Stock (ALDX) Company Profile

Name
명칭
Aldeyra Therapeutics Inc
Name
전화
781-761-4904
Name
주소
131 HARTWELL AVENUE, LEXINGTON, MA
Name
직원
8
Name
트위터
@aldeyraaldx
Name
다음 수익 날짜
2024-11-18
Name
최신 SEC 제출 서류
Name
ALDX's Discussions on Twitter

ALDX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ALDX
Aldeyra Therapeutics Inc
3.40 160.82M 0 -44.80M -30.67M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.90 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
520.64 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
321.58 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
561.89 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
266.62 28.51B 3.81B -644.79M -669.77M -6.24

Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-04-03 업그레이드 Oppenheimer Perform → Outperform
2024-04-02 재개 H.C. Wainwright Buy
2022-04-27 재개 H.C. Wainwright Buy
2021-02-08 개시 H.C. Wainwright Buy
2020-12-16 개시 Berenberg Buy
2020-10-30 개시 Jefferies Buy
2020-10-16 개시 BTIG Research Buy
2020-09-22 개시 Alliance Global Partners Buy
2020-05-12 개시 Oppenheimer Outperform
2018-12-04 개시 Citigroup Buy
2018-09-26 재확인 Cantor Fitzgerald Overweight
2018-09-13 개시 Janney Buy
2018-01-26 개시 Seaport Global Securities Buy
2016-09-26 개시 H.C. Wainwright Buy
2016-07-01 개시 Stifel Buy
2015-07-01 개시 Canaccord Genuity Buy
2015-03-25 개시 Chardan Capital Markets Buy
2015-03-20 재확인 H.C. Wainwright Buy
2014-11-18 개시 H.C. Wainwright Buy
2014-06-19 개시 Aegis Capital Buy
모두보기

Aldeyra Therapeutics Inc 주식(ALDX)의 최신 뉴스

pulisher
Jun 17, 2025

Aldeyra Therapeutics Resubmits Reproxalap NDA in Dry Eye Disease - HCPLive

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra resubmits NDA for dry eye disease drug after trial success - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra resubmits NDA for dry eye disease drug after trial success By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra Therapeutics (ALDX) Resubmits FDA Application for Dry Ey - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra resubmits Reproxalap's marketing application to FDA - Seeking Alpha

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra Therapeutics Resubmits New Drug Application For Dry Eye Drug; Shares Up Pre-Bell - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra Therapeutics Resubmits Reproxalap New Drug Application f - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra (ALDX) Resubmits Drug Application for Dry Eye Treatment to FDA | ALDX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra Resubmits Reproxalap NDA to FDA - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra's Dry Eye Drug Hits Major Trial Goal (P=0.002), FDA Application Resubmitted After Previous Rejection - Stock Titan

Jun 17, 2025
pulisher
Jun 11, 2025

Aldeyra Therapeutics Holds Annual Meeting with Key Votes - TipRanks

Jun 11, 2025
pulisher
Jun 10, 2025

Trend Tracker for (ALDX) - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 08, 2025

Two Sigma Investments LP Sells 15,349 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

161,926 Shares in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Purchased by Millennium Management LLC - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

SHAREHOLDER ALERT: Potential Recovery for Aldeyra Therapeutics, Inc. (ALDX) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

Jun 07, 2025
pulisher
Jun 06, 2025

Mackenzie Financial Corp Purchases 36,160 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

BNP Paribas Financial Markets Trims Stake in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Bank of America Corp DE Reduces Stock Position in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

ProShare Advisors LLC Acquires Shares of 14,031 Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Two Sigma Advisers LP Sells 84,000 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Jun 04, 2025
pulisher
May 29, 2025

Trading (ALDX) With Integrated Risk Controls - news.stocktradersdaily.com

May 29, 2025
pulisher
May 29, 2025

Aldeyra Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference | ALDX Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Aldeyra Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference - Business Wire

May 29, 2025
pulisher
May 26, 2025

Northern Trust Corp Purchases 16,894 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 26, 2025
pulisher
May 25, 2025

Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Shares Acquired by Deutsche Bank AG - Defense World

May 25, 2025
pulisher
May 24, 2025

D. E. Shaw & Co. Inc. Sells 146,198 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 24, 2025
pulisher
May 23, 2025

Q3 Earnings Forecast for ALDX Issued By Leerink Partnrs - Defense World

May 23, 2025
pulisher
May 22, 2025

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX): When Will It Breakeven? - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

HC Wainwright Has Strong Forecast for ALDX FY2029 Earnings - Defense World

May 22, 2025
pulisher
May 22, 2025

Q2 EPS Estimate for Aldeyra Therapeutics Lifted by Analyst - Defense World

May 22, 2025
pulisher
May 21, 2025

Aldeyra Therapeutics (NASDAQ:ALDX) Raised to “Sell” at StockNews.com - Defense World

May 21, 2025
pulisher
May 20, 2025

Balyasny Asset Management L.P. Acquires New Stake in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 20, 2025
pulisher
May 20, 2025

Aldeyra Therapeutics (NASDAQ:ALDX) Given “Buy” Rating at HC Wainwright - Defense World

May 20, 2025
pulisher
May 19, 2025

ALDX: HC Wainwright & Co. Reiterates Buy Rating with $10 Target | ALDX Stock News - GuruFocus

May 19, 2025
pulisher
May 18, 2025

(ALDX) Trading Report - news.stocktradersdaily.com

May 18, 2025
pulisher
May 18, 2025

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc.ALDX - FinancialContent

May 18, 2025
pulisher
May 18, 2025

Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Stock Holdings Lessened by Price T Rowe Associates Inc. MD - Defense World

May 18, 2025
pulisher
May 14, 2025

Bragar Eagel & Squire, P.C. Is Investigating Organon, Aldeyra, Landstar, and ICU Medical ... - Eagle-Tribune

May 14, 2025
pulisher
May 14, 2025

Bragar Eagel & Squire, P.C. Is Investigating Organon, - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Aldeyra Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 13, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aldeyra - Bluefield Daily Telegraph

May 13, 2025
pulisher
May 13, 2025

Hsbc Holdings PLC Acquires Shares of 10,457 Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 13, 2025
pulisher
May 12, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc.ALDX - PR Newswire

May 12, 2025
pulisher
May 11, 2025

SHAREHOLDER ALERT: Potential Recovery for Aldeyra Therapeutics, Inc. (ALDX) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

May 11, 2025
pulisher
May 11, 2025

Barclays PLC Has $376,000 Stake in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 11, 2025
pulisher
May 08, 2025

(ALDX) Trading Advice - news.stocktradersdaily.com

May 08, 2025
pulisher
May 08, 2025

Bragar Eagel & Squire, P.C. Is Investigating RobinHood, - GlobeNewswire

May 08, 2025
pulisher
May 07, 2025

Bragar Eagel & Squire, P.C. Is Investigating RobinHood, Aldeyra, Landstar, and ICU Medical ... - Eagle-Tribune

May 07, 2025
pulisher
May 07, 2025

Bragar Eagel & Squire, P.C. Is Investigating RobinHood, Aldeyra, Landstar, and ICU Medical and Encourages Investors to Contact the Firm - TradingView

May 07, 2025
pulisher
May 07, 2025

Aldeyra Therapeutics Drops To US$2.10, Yet Insiders May Have Sold Too Early - simplywall.st

May 07, 2025
pulisher
May 07, 2025

ALDX SECURITIES UPDATE: Aldeyra Therapeutics Investors with - GlobeNewswire

May 07, 2025

Aldeyra Therapeutics Inc (ALDX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Aldeyra Therapeutics Inc 주식 (ALDX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Machatha Stephen
Chief Development Officer
Aug 12 '24
Sale
4.74
16,041
75,975
236,771
Greenberg Bruce
See Remarks
Aug 12 '24
Sale
4.74
10,834
51,313
126,382
$20.46
price down icon 1.45%
$35.73
price down icon 1.13%
$20.65
price down icon 1.36%
$105.17
price down icon 0.80%
$103.92
price down icon 1.26%
biotechnology ONC
$266.77
price down icon 0.05%
자본화:     |  볼륨(24시간):